Abstract
In this chapter, we summarise the current knowledge about a group of clinically diverse neurological syndromes that are unified by a common pathophysiology, mostly immune-mediated neuronal dysfunction or degeneration triggered by a distant tumour and thus are coined paraneoplastic neurological syndromes (PNS). In the majority of cases, antibodies against onconeural, intracellular antigens expressed by the tumour and the nervous system can be detected in serum and cerebrospinal fluid. Some clinical pictures are suggestive of an underlying PNS. These syndromes include progressive cerebellar degeneration, encephalomyelitis, limbic encephalitis, opsoclonus-myoclonus syndrome, subacute sensory neuronopathy, chronic gastrointestinal pseudo-obstruction and Lambert-Eaton myasthenic syndrome. These clinical manifestations are called classical paraneoplastic syndromes. Other neurological syndromes like brainstem encephalitides or neuropathies can have diverse aetiologies, amongst which a tumour-triggered immune response is one possibility amongst many others. The detection of onconeural antibodies in suspected PNS confirms the diagnosis and aids in diagnosis, tumour search and therapy. Here, we summarise the practical approach, typical findings and the most important syndromes including electrophysiological tests, imaging and cerebrospinal fluid analysis. Not obligatorily paraneoplastic autoimmune encephalitides associated with antibodies against neuronal surface proteins are covered by a separate chapter of this book.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarawal SK, Birch BR, Abercrombie GF (1995) Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association. Scand J Urol Nephrol 29:351–353
Ahmed MN, Carpenter S (1975) Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J 113:410–412
Alamowitch S, Graus F, Uchuya M et al (1997) Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 120(Pt 6):923–928
Ali K, Amin R, Yoganathan KG et al (2013) Rapidly progressive cerebellar ataxia in West Wales. BMJ Case Rep 2013
Altman AJ, Baehner RL (1976) Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer 37:846–852
Anderson NE, Rosenblum MK, Posner JB (1988a) Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 24:559–567
Anderson NE, Budde-Steffen C, Rosenblum MK et al (1988b) Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) 67:100–109
Anonymous (2001) Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve 24:1236–1238
Antunes NL, Khakoo Y, Matthay KK et al (2000) Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 22:315–320
Armangue T, Titulaer MJ, Sabater L et al (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75:435–441
Badari A, Farolino D, Nasser E et al (2012) A novel approach to paraneoplastic intestinal pseudo-obstruction. Support Care Cancer 20:425–428
Bataller L, Graus F, Saiz A et al (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124:437–443
Bataller L, Rosenfeld MR, Graus F et al (2003) Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 53:347–353
Bataller L, Wade DF, Graus F et al (2004) Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62:778–782
Bataller L, Kleopa KA, Wu GF et al (2007) Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry 78:381–385
Battaglia T, De Grandis E, Mirabelli-Badenier M et al (2012) Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. Eur J Paediatr Neurol 16:192–195
Belcastro V, Piola M, Binda S et al (2014) Opsoclonus-myoclonus syndrome associated with human herpes virus-6 rhomboencephalitis. J Neurol Sci 341:165–166
Bellur SN (1975) Opsoclonus: its clinical value. Neurology 25:502–507
Bernal F, Shams’ili S, Rojas I et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 60:230–234
Bhandari HS (2012) Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies. BMJ Case Rep 2012
Bhanushali MJ, Kranick SM, Freeman AF et al (2013) Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 80:1494–1500
BirluTiu V, BirluTiu RM (2014) Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report. J Med Case Rep 8:232
Blaes F, Fuhlhuber V, Korfei M et al (2005) Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 58:313–317
Boltshauser E, Deonna T, Hirt HR (1979) Myoclonic encephalopathy of infants or “dancing eyes syndrome”. Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Helv Paediatr Acta 34:119–133
Boronat A, Sabater L, Saiz A et al (2011) GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76:795–800
Boronat A, Gelfand JM, Gresa-Arribas N et al (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73:120–128
Bozzola E, Bozzola M, Tozzi AE et al (2014) Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr 40:57
Briani C, Vitaliani R, Grisold W et al (2011) Spectrum of paraneoplastic disease associated with lymphoma. Neurology 76:705–710
Brunklaus A, Pohl K, Zuberi SM et al (2012) Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome. Arch Dis Child 97:461–463
Buchanan TA, Gardiner TA, Archer DB (1984) An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol 97:277–287
Butler MH, Hayashi A, Ohkoshi N et al (2000) Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 26:307–312
Butterworth RF (1993) Pathophysiology of cerebellar dysfunction in the Wernicke-Korsakoff syndrome. Can J Neurol Sci 20(Suppl 3):S123–S126
Camdessanche JP, Jousserand G, Ferraud K et al (2009) The pattern and diagnostic criteria of sensory neuronopathy: a case–control study. Brain 132:1723–1733
Candler PM, Hart PE, Barnett M et al (2004) A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 75:1411–1415
Caviness JN, Forsyth PA, Layton DD et al (1995) The movement disorder of adult opsoclonus. Mov Disord 10:22–27
Chinn JS, Schuffler MD (1988) Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 95:1279–1286
Choi KD, Kim JS, Park SH et al (2006) Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 77:525–528
Conklin JL, Anuras S (1981) Radiation-induced recurrent intestinal pseudo-obstruction. Am J Gastroenterol 75:440–444
Connolly AM, Pestronk A, Mehta S et al (1997) Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 130:878–884
Corsellis JA, Goldberg GJ, Norton AR (1968) “Limbic encephalitis” and its association with carcinoma. Brain 91:481–496
Cross SA, Salomao DR, Parisi JE et al (2003) Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 54:38–50
Cunningham J, Graus F, Anderson N et al (1986) Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 36:1163–1168
Dalmau J, Furneaux HM, Gralla RJ et al (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer–a quantitative western blot analysis. Ann Neurol 27:544–552
Dalmau J, Graus F, Rosenblum MK et al (1992) Anti-Hu–associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 71:59–72
Dalmau J, Graus F, Cheung NK et al (1995) Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75:99–109
Dalmau J, Graus F, Villarejo A et al (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain 127:1831–1844
de Graaff E, Maat P, Hulsenboom E et al (2012) Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol 71:815–824
DeFelipe-Mimbrera A, Masjuan J, Corral I et al (2014) Opsoclonus-myoclonus syndrome and limbic encephalitis associated with GABAB receptor antibodies in CSF. J Neuroimmunol 272:91–93
Denny-Brown D (1948) Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 11:73–87
Dispenzieri A (2007) POEMS syndrome. Blood Rev 21:285–299
Fisher PG, Wechsler DS, Singer HS (1994) Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol 10:309–312
Flanagan EP, McKeon A, Lennon VA et al (2011) Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76:2089–2095
Forsyth PA, Dalmau J, Graus F et al (1997) Motor neuron syndromes in cancer patients. Ann Neurol 41:722–730
Fukuda T, Motomura M, Nakao Y et al (2003) Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann Neurol 53:21–28
Gill JS, Windebank AJ (1998) Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 101:2842–2850
Giometto B, Marchiori GC, Nicolao P et al (1997) Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 23:468–474
Giometto B, Grisold W, Vitaliani R et al (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330–335
Giometto B, Vitaliani R, Lindeck-Pozza E et al (2012) Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 12, CD007625
Gohil A, Croffie JM, Fitzgerald JF et al (2001) Reversible intestinal pseudoobstruction associated with neural crest tumors. J Pediatr Gastroenterol Nutr 33:86–88
Granerod J, Ambrose HE, Davies NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844
Grau-Rivera O, Sanchez-Valle R, Saiz A et al (2014) Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease. JAMA Neurol 71:74–78
Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538–543
Graus F, Elkon KB, Lloberes P et al (1987) Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol Scand 75:249–252
Graus F, Segurado OG, Tolosa E (1988) Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand 78:210–213
Graus F, Dalmou J, Rene R et al (1997) Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15:2866–2872
Graus F, Keime-Guibert F, Rene R et al (2001) Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124:1138–1148
Graus F, Lang B, Pozo-Rosich P et al (2002) P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59:764–766
Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Graus F, Arino H, Dalmau J (2014) Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood 123:3230–3238
Greene M, Lai Y, Baella N et al (2014) Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma. JAMA Neurol 71:1003–1008
Greenlee JE (2013) Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol 15:185–200
Greenlee JE, Steffens JD, Clawson SA et al (2002) Anti-Hu antibodies in Merkel cell carcinoma. Ann Neurol 52:111–115
Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167–177
Griffin JW, Cornblath DR, Alexander E et al (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren’s syndrome. Ann Neurol 27:304–315
Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123(Pt 7):1481–1494
Hart IK, Maddison P, Newsom-Davis J et al (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895
Hatanaka Y, Oh SJ (2008) Ten-second exercise is superior to 30-second exercise for post-exercise facilitation in diagnosing Lambert-Eaton myasthenic syndrome. Muscle Nerve 37:572–575
Hattori T, Hirayama K, Imai T et al (1988) Pontine lesion in opsoclonus-myoclonus syndrome shown by MRI. J Neurol Neurosurg Psychiatry 51:1572–1575
Hayward K, Jeremy RJ, Jenkins S et al (2001) Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr 139:552–559
Henson RA, Hoffman HL, Urich H (1965) Encephalomyelitis with carcinoma. Brain 88:449–464
Hoftberger R, Kovacs GG, Sabater L et al (2013) Protein kinase C gamma antibodies and paraneoplastic cerebellar degeneration. J Neuroimmunol 256:91–93
Honnorat J, Antoine JC, Derrington E et al (1996) Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 61:270–278
Honnorat J, Saiz A, Giometto B et al (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225–230
Ingenito GG, Berger JR, David NJ et al (1990) Limbic encephalitis associated with thymoma. Neurology 40:382
Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241–255
Jacobson DM, Thirkill CE, Tipping SJ (1990) A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 28:162–167
Jarius S, Stich O, Rasiah C et al (2008) Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. J Neurol Sci 268:65–68
Jarius S, Eichhorn P, Jacobi C et al (2009) The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity? J Neurol Sci 280:98–100
Jarius S, Martinez-Garcia P, Hernandez AL et al (2013) Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation 10:7
Jones HR Jr, Hedley-Whyte ET, Freidberg SR et al (1982) Primary cerebellopontine progressive multifocal leukoencephalopathy diagnosed premortem by cerebellar biopsy. Ann Neurol 11:199–202
Keltner JL, Thirkill CE, Yip PT (2001) Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173–187
Keogh M, Sedehizadeh S, Maddison P (2011) Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database Syst Rev (2):CD003279
Khasani S, Becker K, Meinck HM (2004) Hyperekplexia and stiff-man syndrome: abnormal brainstem reflexes suggest a physiological relationship. J Neurol Neurosurg Psychiatry 75:1265–1269
Kim H, Lim Y, Kim KK (2009) Anti-ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI. J Clin Neurol 5:151–152
Kimmel DW, O’Neill BP, Lennon VA (1988) Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. Mayo Clin Proc 63:29–32
Kinsbourne M (1962) Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 25:271–276
Klaas JP, Ahlskog JE, Pittock SJ et al (2012) Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol 69:1598–1607
Koike H, Tanaka F, Sobue G (2011) Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 24:504–510
Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H et al (2007) Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies. Brain 130:1076–1088
Kulling D, Reed CE, Verne GN et al (1997) Intestinal pseudo-obstruction as a paraneoplastic manifestation of malignant thymoma. Am J Gastroenterol 92:1564–1566
Kurian M, Lalive PH, Dalmau JO et al (2010) Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis. Arch Neurol 67:118–121
Lancaster E, Dalmau J (2012) Neuronal autoantigens–pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8:380–390
Lancaster E, Martinez-Hernandez E, Titulaer MJ et al (2011) Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 77:1698–1701
Lauritzen M, Smith T, Fischer-Hansen B et al (1980) Eaton-Lambert syndrome and malignant thymoma. Neurology 30:634–638
Lawn ND, Westmoreland BF, Kiely MJ et al (2003) Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78:1363–1368
Lennon VA (1994) The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies. Neurology 44:2412–2415
Lennon VA, Sas DF, Busk MF et al (1991) Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 100:137–142
Levy LM, Dalakas MC, Floeter MK (1999) The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 131:522–530
Leypoldt F, Eichhorn P, Saager C et al (2006) Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis. J Neurol Neurosurg Psychiatry 77:1199–1200
Li J, Zhou DB (2013) New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol 161:303–315
Lucchinetti CF, Kimmel DW, Lennon VA (1998) Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50:652–657
Luque FA, Furneaux HM, Ferziger R et al (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241–251
Mason WP, Graus F, Lang B et al (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120(Pt 8):1279–1300
Maverakis E, Goodarzi H, Wehrli LN et al (2012) The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol 42:135–144
McKeon A, Lennon VA, Lachance DH et al (2009) Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 66:735–741
McKeon A, Tracy JA, Pittock SJ et al (2011a) Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol 68:1282–1289
McKeon A, Pittock SJ, Lennon VA (2011b) CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology 76:1108–1110
McKeon A, Robinson MT, McEvoy KM et al (2012) Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol 69:230–238
McKeon A, Martinez-Hernandez E, Lancaster E et al (2013) Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 70:44–50
Meinck HM, Ricker K, Hulser PJ et al (1994) Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol 241:157–166
Moersch FP, Woltman HW (1956) Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin 31:421–427
Molinuevo JL, Graus F, Serrano C et al (1998) Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 44:976–980
Monstad SE, Knudsen A, Salvesen HB et al (2009) Onconeural antibodies in sera from patients with various types of tumours. Cancer Immunol Immunother 58:1795–1800
Morimoto M, Osaki T, Nagara Y et al (2010) Thymoma with Lambert-Eaton myasthenic syndrome. Ann Thorac Surg 89:2001–2003
Murinson BB, Guarnaccia JB (2008) Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 71:1955–1958
Musthafa CP, Moosa A, Chandrashekharan PA et al (2006) Intestinal pseudo-obstruction as initial presentation of thymoma. Indian J Gastroenterol 25:264–265
Nakao YK, Motomura M, Fukudome T et al (2002) Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology 59:1773–1775
Newman NJ, Bell IR, McKee AC (1990) Paraneoplastic limbic encephalitis: neuropsychiatric presentation. Biol Psychiatry 27:529–542
O’Neill JH, Murray NM, Newsom-Davis J (1988) The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111(Pt 3):577–596
Ojeda VJ (1984) Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review. Cancer 53:1115–1123
Ongerboer de Visser BW (1983) Anatomical and functional organization of reflexes involving the trigeminal system in man: jaw reflex, blink-reflex, corneal reflex and exteroceptive suppression. In: Desmedt JE (ed) Motor control mechanisms in health and disease. Raven Press, New York, pp 727–738
Pande R, Leis AA (1999) Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 22:1600–1602
Panegyres PK, Reading MC, Esiri MM (1993) The inflammatory reaction of paraneoplastic ganglionitis and encephalitis: an immunohistochemical study. J Neurol 240:93–97
Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65:629–632
Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580–587
Pittock SJ, Parisi JE, McKeon A et al (2010) Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol 67:1109–1115
Polans AS, Buczylko J, Crabb J et al (1991) A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 112:981–989
Polans AS, Witkowska D, Haley TL et al (1995) Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A 92:9176–9180
Pranzatelli MR (1992) The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 15:186–228
Psimaras D, Carpentier AF, Rossi C (2010) Cerebrospinal fluid study in paraneoplastic syndromes. J Neurol Neurosurg Psychiatry 81:42–45
Racalbuto A, Magro G, Lanteri R et al (2008) Idiopathic myenteric ganglionitis underlying acute ‘dramatic’ intestinal pseudoobstruction: report of an exceptional case. Case Rep Gastroenterol 2:461–468
Rakocevic G, Barohn R, McVey AL et al (2003) Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review. J Clin Neuromuscul Dis 5:93–95
Rauer S, Kaiser R (2000) Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system. J Neuroimmunol 111:241–244
Rauer S, Kaiser R (2001) Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes. Acta Neurol Scand 103:248–254
Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319–328
Roberts A, Perera S, Lang B et al (1985) Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature 317:737–739
Rosenfeld MR, Posner JB (1991) Paraneoplastic motor neuron disease. In: Rowland LP (ed) Advances in neurology: amyotrophic lateral sclerosis and other motor neuron diseases. Raven Press, New York, pp 445–459
Rudnicki SA, Dalmau J (2005) Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 18:598–603
Sabater L, Bataller L, Carpentier AF et al (2006) Protein kinase C gamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry 77:1359–1362
Sabater L, Titulaer M, Saiz A et al (2008) SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 70:924–928
Saiz A, Graus F, Dalmau J et al (1999) Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 46:774–777
Saiz A, Bruna J, Stourac P et al (2009) Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry 80:404–407
Schuffler MD, Rohrmann CA, Chaffee RG et al (1981) Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature. Medicine (Baltimore) 60:173–196
Shams’ili S, Grefkens J, de Leeuw B et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409–1418
Sipponen T, Karikoski R, Nuutinen H et al (2009) Three-generation familial visceral myopathy with alpha-actin-positive inclusion bodies in intestinal smooth muscle. J Clin Gastroenterol 43:437–443
Skeie GO, Romi F (2008) Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol 15:1029–1033
Smith JH, Dhamija R, Moseley BD et al (2011) N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol 68:1069–1072
Sommer C, Weishaupt A, Brinkhoff J et al (2005) Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 365:1406–1411
Stich O, Rauer S (2007) Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2/CRMP5 associated paraneoplastic neurological syndromes. Eur J Neurol 14:650–653
Stich O, Graus F, Rasiah C et al (2003) Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 141:165–169
Stich O, Jarius S, Kleer B et al (2007) Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. J Neuroimmunol 183:220–224
Stork AC, van der Pol WL, Franssen H et al (2014) Clinical phenotype of patients with neuropathy associated with monoclonal gammopathy: a comparative study and a review of the literature. J Neurol 261:1398–1404
Storstein A, Krossnes B, Vedeler CA (2006) Autopsy findings in the nervous system and ovarian tumour of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand Suppl 183:69–70
Sutton IJ, Barnett MH, Watson JD et al (2002) Paraneoplastic brainstem encephalitis and anti-Ri antibodies. J Neurol 249:1597–1598
Tagliati M, Simpson D, Morgello S et al (1998) Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology 50:244–251
Talon P, Stoll C (1985) Opsomyoclonus syndrome in children. A new case. Review of the literature (110 cases). Pediatrie 40:441–449
Teixeira AR, Nitz N, Guimaro MC et al (2006) Chagas disease. Postgrad Med J 82:788–798
Tetu B, Ro JY, Ayala AG et al (1989) Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 33:148–152
Titulaer MJ, Klooster R, Potman M et al (2009) SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol 27:4260–4267
Titulaer MJ, Soffietti R, Dalmau J et al (2011a) Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 18:19–e13
Titulaer MJ, Lang B, Verschuuren JJ (2011b) Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10:1098–1107
Titulaer MJ, Maddison P, Sont JK et al (2011c) Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol 29:902–908
Valls-Sole J, Graus F, Font J et al (1990) Normal proprioceptive trigeminal afferents in patients with Sjogren’s syndrome and sensory neuronopathy. Ann Neurol 28:786–790
Vernino S, Tuite P, Adler CH et al (2002) Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 51:625–630
Voltz R, Gultekin SH, Rosenfeld MR et al (1999) A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340:1788–1795
Wald A, Kichler J, Mendelow H (1981) Amyloidosis and chronic intestinal pseudoobstruction. Dig Dis Sci 26:462–465
Wanschitz J, Hainfellner JA, Kristoferitsch W et al (1997) Ganglionitis in paraneoplastic subacute sensory neuronopathy: a morphologic study. Neurology 49:1156–1159
Weinstein JM, Kelman SE, Bresnick GH et al (1994) Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 101:1236–1243
Wildhaber B, Niggli F, Stallmach T et al (2002) Intestinal pseudoobstruction as a paraneoplastic syndrome in ganglioneuroblastoma. Eur J Pediatr Surg 12:429–431
Yamamoto AM, Gajdos P, Eymard B et al (2001) Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 58:885–890
Young CA, MacKenzie JM, Chadwick DW et al (1993) Opsoclonus-myoclonus syndrome: an autopsy study of three cases. Eur J Med 2:239–241
Yu Z, Kryzer TJ, Griesmann GE et al (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49:146–154
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lewerenz, J., Leypoldt, F. (2015). Paraneoplastic Neurological Syndromes. In: Deisenhammer, F., Sellebjerg, F., Teunissen, C., Tumani, H. (eds) Cerebrospinal Fluid in Clinical Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-01225-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-01225-4_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01224-7
Online ISBN: 978-3-319-01225-4
eBook Packages: MedicineMedicine (R0)